Progenics Pharmaceuticals Provides Update on Reconstituted Board’s Ongoing Strategic Review

Ads

You May Also Like

Orion upgrades full-year outlook for 2016

ORION CORPORATION      STOCK EXCHANGE RELEASE 15 JUNE 2016 at 10:20 a.m. EEST  Orion upgrades ...

Immunovaccine Announces Year-End 2017 Financial Results

HALIFAX, Nova Scotia, March 20, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...